4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001209191-23-049135
Chief Transformation Officer sold 846 shares at $4.62 ($3,912)
- Chief Transformation Officer acquired 2,841 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saad Kareem Chief Transformation Officer | 2023-09-09 | Option exercise | +2,841 | 15,283 | D | ||
| Saad Kareem Chief Transformation Officer | 2023-09-11 | Sale | −846 | $4.62 | $3,912 | 14,437 | D |
| Derivatives | |||||||
| Saad Kareem Chief Transformation Officer | 2023-09-09 | Option exercise · Restricted Stock Unit | −2,841 | 36,931 | D | ||
| Open-market sales · 846 sh · avg $4.62 · $3,912 | |||||||
Loading xslF345X05/doc4.xml…